A new analysis of global allergy research from 2016 to 2025 shows that scientific publications on allergic disorders are growing at 7.59% each year. The review looked at 1,543 publications from major databases and found that most studies focus on risk factors, making up 83 to 89 percent of the research across all allergic conditions. However, studies that measure the actual burden of disease, such as how many people are affected, how severe the illness is, or its impact on quality of life, are consistently scarce.
The research also revealed that the field is geographically concentrated, with most work coming from a few countries. This imbalance means that findings may not apply to people in other parts of the world. The review did not report any safety concerns or side effects, as it was not a clinical trial but a mapping of existing literature.
Because this is a bibliometric review, it describes trends in research output rather than testing a new treatment or finding a cause. The main limitation is that the data only come from two large databases, which may miss some studies. Readers should understand that while allergy research is growing, there are important gaps in understanding the true burden of allergic diseases worldwide.
